Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.35 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.35 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1921735 | 1.00 | CYP1A2 (0.41) | CYP1A2CYP2D6MAPTCYP2C9CYP2C19 | |
| SCHEMBL11940662 | 0.79 | ACLY (0.48) | CYP1A2CYP2D6MAPTCYP2C9CYP2C19 | |
| SCHEMBL9256362 | 0.79 | CYP2D6 (0.43) | CYP1A2CYP2D6MAPTCYP2C9CYP2C19 | |
| SCHEMBL600647 | 0.76 | ARG1 (0.52) | CYP1A2CYP2D6MAPTCYP2C9CYP2C19 | |
| SCHEMBL601002 | 0.76 | ARG1 (0.52) | CYP1A2CYP2D6MAPTCYP2C9CYP2C19 | |
| SCHEMBL600648 | 0.76 | ARG1 (0.52) | CYP1A2CYP2D6MAPTCYP2C9CYP2C19 | |
| SCHEMBL18492198 | 0.73 | CYP1A2 (0.38) | CYP1A2CYP2D6MAPTCYP2C9CYP2C19 | |
| SCHEMBL20021202 | 0.73 | CYP1A2 (0.38) | CYP1A2CYP2D6MAPTCYP2C9CYP2C19 | |
| SCHEMBL4963018 | 0.71 | MAPT (0.39) | CYP1A2CYP2D6MAPTCYP2C9CYP2C19 | |
| SCHEMBL601232 | 0.71 | ARG1 (0.55) | CYP1A2CYP2D6MAPTCYP2C9CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2342214-A1 | PEPTIDOMIMETIC MACROCYCLES | Aileron Therapeutics, Inc. (US) | 2011-07-13 | — | — | EP | disclosed |
| EP-2331567-A1 | PEPTIDOMIMETIC MACROCYCLES | Aileron Therapeutics, Inc. (US) | 2011-06-15 | — | — | EP | disclosed |
| EP-2329015-A1 | PEPTIDOMIMETIC MACROCYCLES | Aileron Therapeutics, Inc. (US) | 2011-06-08 | — | — | EP | disclosed |
| WO-2010034028-A1 | PEPTIDOMIMETIC MARCROCYCLES | AILERON THERAPEUTICS, INC. (US) | 2010-03-25 | — | — | WO | disclosed |
| WO-2010034029-A1 | PEPTIDOMIMETIC MACROCYCLES | AILERON THERAPEUTICS, INC. (US) | 2010-03-25 | — | — | WO | disclosed |
| WO-2010034026-A1 | PEPTIDOMIMETIC MACROCYCLES | AILERON THERAPEUTICS, INC. (US) | 2010-03-25 | — | — | WO | disclosed |